Coreg and Ocular icterus - a phase IV clinical study of FDA data

Summary:

Ocular icterus is reported as a side effect among people who take Coreg (carvedilol), especially for people who are female, 50-59 old, have been taking the drug for 1 - 6 months also take Lasix, and have Nuclear magnetic resonance imaging abdominal.

The phase IV clinical study analyzes which people have Ocular icterus when taking Coreg. It is created by eHealthMe based on reports of 48,155 people who have side effects when taking Coreg from the FDA, and is updated regularly.

What is Coreg?

Coreg has active ingredients of carvedilol. It is often used in high blood pressure. eHealthMe is studying from 49,583 Coreg users. Check the latest studies of Coreg.

What is Ocular icterus?

Ocular icterus (presence of jaundice seen in the sclera of the eye) is found to be associated with 509 drugs and 782 conditions by eHealthMe. Check the latest studies of Ocular icterus.

On Jul, 14, 2026

48,155 people reported to have side effects when taking Coreg.
Among them, 19 people (0.04%) have Ocular icterus.

Among these 19 people:

How long have people been on Coreg when they have Ocular icterus? *

What is the gender of people who have Ocular icterus when taking Coreg? *

female: 78.95 %
male: 21.05 %

What is the age of people who have Ocular icterus when taking Coreg? *

What are other drugs people take besides Coreg? *

What are other side effects people have besides Ocular icterus? *

Oedema (fluid collection in tissue): 13 people, 68.42%
Pain In Extremity: 11 people, 57.89%
Oedema Peripheral (superficial swelling): 10 people, 52.63%
Rashes (redness): 10 people, 52.63%
Skin Exfoliation (removal of the oldest dead skin cells): 8 people, 42.11%
Nephrogenic Systemic Fibrosis (involves fibrosis of skin, joints, eyes due to kidney disease): 7 people, 36.84%
Skin Discoloration: 7 people, 36.84%
Blood Bilirubin Increased: 7 people, 36.84%
Burning Sensation: 7 people, 36.84%
Skin Induration (an abnormally hard spot or area on the skin): 7 people, 36.84%

What are the existing conditions these people have? *

Nuclear Magnetic Resonance Imaging Abdominal: 5 people, 26.32%
Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 3 people, 15.79%
Cardiac Disorder: 2 people, 10.53%
Diabetes: 2 people, 10.53%
Nuclear Magnetic Resonance Imaging Brain: 2 people, 10.53%
High Blood Cholesterol: 2 people, 10.53%
Hyperthyroidism (over activity of the thyroid gland): 1 person, 5.26%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 1 person, 5.26%
Cardiac Failure Congestive: 1 person, 5.26%
Depression: 1 person, 5.26%

* Approximation only. Some reports may have incomplete information.

Do you take Coreg and have Ocular icterus?

- Check whether Ocular icterus is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Coreg:

Coreg (49,583 reports)

Ocular icterus treatments and more:

Ocular icterus (5,127 reports)

Browse all side effects of Coreg:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Ocular icterus:

Ocular icterus (509 drugs)

Browse all the conditions that are associated with Ocular icterus:

Ocular icterus (782 conditions)

Related publications that referenced our studies

Barold, S. S., & Upton, S. , "Hyperkalemia Induced by the Sequential Administration of Metoprolol and Carvedilol", Case reports in cardiology, 2018 Jan .
Kim MS, Baek IH, "Effect of dronedarone on the pharmacokinetics of carvedilol following oral administration to rats", European Journal of Pharmaceutical Sciences, 2018 Jan .
Barold, S. S., & Upton, S. , "Hyperkalemia Induced by the Sequential Administration of Metoprolol and Carvedilol", Case reports in cardiology, 2018 Jan .
Kim MS, Baek IH, "Effect of dronedarone on the pharmacokinetics of carvedilol following oral administration to rats", European Journal of Pharmaceutical Sciences, 2018 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on carvedilol (the active ingredients of Coreg) and Coreg (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.